At the start of this year, shares in Synairgen were valued at less than 6p. By July 17, the biotech firm’s share price had risen to 36p, and by close of play on Friday the shares had shot up to £2.04.
MIDAS UPDATE: Time to cash in half your shares in Synairgen
Something you may find interesting…
[recent_products per_page="4" columns="4" orderby="rand" order="rand"]